These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38493315)

  • 1. Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients.
    Aykanli E; Arisan S; Arisan ED; Yavuzsan AH
    Urol J; 2024 May; 21(3):182-188. PubMed ID: 38493315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.
    Daniūnaitė K; Berezniakovas A; Jankevičius F; Laurinavičius A; Lazutka JR; Jarmalaitė S
    Medicina (Kaunas); 2011; 47(3):147-53. PubMed ID: 21822036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis.
    Dumache R; Puiu M; Motoc M; Vernic C; Dumitrascu V
    Clin Lab; 2014; 60(5):847-52. PubMed ID: 24839830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The investigation of GSTP1, APC and RASSF1 gene promoter hypermethylation in urine DNA of prostate-diseased patients.
    Haluskova J; Lachvac L; Nagy V
    Bratisl Lek Listy; 2015; 116(2):79-82. PubMed ID: 25665470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.
    Trock BJ; Brotzman MJ; Mangold LA; Bigley JW; Epstein JI; McLeod D; Klein EA; Jones JS; Wang S; McAskill T; Mehrotra J; Raghavan B; Partin AW
    BJU Int; 2012 Jul; 110(1):56-62. PubMed ID: 22077694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
    Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
    Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
    Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
    Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GCPII modulates oxidative stress and prostate cancer susceptibility through changes in methylation of RASSF1, BNIP3, GSTP1 and Ec-SOD.
    Divyya S; Naushad SM; Murthy PV; Reddy ChR; Kutala VK
    Mol Biol Rep; 2013 Oct; 40(10):5541-50. PubMed ID: 23979608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies.
    Van Neste L; Partin AW; Stewart GD; Epstein JI; Harrison DJ; Van Criekinge W
    Prostate; 2016 Sep; 76(12):1078-87. PubMed ID: 27121847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis.
    Wu T; Giovannucci E; Welge J; Mallick P; Tang WY; Ho SM
    Br J Cancer; 2011 Jun; 105(1):65-73. PubMed ID: 21654682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection.
    Van Neste L; Bigley J; Toll A; Otto G; Clark J; Delrée P; Van Criekinge W; Epstein JI
    BMC Urol; 2012 Jun; 12():16. PubMed ID: 22672250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSTP1 methylation in cancer: a liquid biopsy biomarker?
    Gurioli G; Martignano F; Salvi S; Costantini M; Gunelli R; Casadio V
    Clin Chem Lab Med; 2018 Apr; 56(5):702-717. PubMed ID: 29305565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [GSTP1, APC and RASSF1 gene methylation in prostate cancer samples: comparative analysis of MS-HRM method and Infinium HumanMethylation450 BeadChip beadchiparray diagnostic value].
    Skorodumova LO; Babalyan KA; Sultanov R; Vasiliev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Generozov EV; Larin AK; Kostryukova ES; Sharova EI
    Biomed Khim; 2016 Nov; 62(6):708-714. PubMed ID: 28026816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of DNA methylation in multifocal prostate cancer.
    Serenaite I; Daniunaite K; Jankevicius F; Laurinavicius A; Petroska D; Lazutka JR; Jarmalaite S
    Virchows Arch; 2015 Jan; 466(1):53-9. PubMed ID: 25369892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LGALS3 cfDNA methylation in seminal fluid as a novel prostate cancer biomarker outperforming PSA.
    Abramovic I; Pezelj I; Dumbovic L; Skara Abramovic L; Vodopic T; Bulimbasic S; Stimac G; Bulic-Jakus F; Kulis T; Katusic Bojanac A; Tomas D; Ulamec M; Sincic N
    Prostate; 2024 Sep; 84(12):1128-1137. PubMed ID: 38824441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging.
    Bakavicius A; Daniunaite K; Zukauskaite K; Barisiene M; Jarmalaite S; Jankevicius F
    Clin Epigenetics; 2019 Aug; 11(1):115. PubMed ID: 31383039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer.
    Papadopoulou E; Davilas E; Sotiriou V; Georgakopoulos E; Georgakopoulou S; Koliopanos A; Aggelakis F; Dardoufas K; Agnanti NJ; Karydas I; Nasioulas G
    Ann N Y Acad Sci; 2006 Sep; 1075():235-43. PubMed ID: 17108217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis.
    Yoon HY; Kim SK; Kim YW; Kang HW; Lee SC; Ryu KH; Shon HS; Kim WJ; Kim YJ
    J Biomol Screen; 2012 Aug; 17(7):987-92. PubMed ID: 22511308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy.
    Rabiau N; Thiam MO; Satih S; Guy L; Kemeny JL; Boiteux JP; Fontana L; Bignon YJ; Bernard-Gallon D
    In Vivo; 2009; 23(3):387-91. PubMed ID: 19454503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.